Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million

GOTHENBURG, Sweden, June 30, 2026 /PRNewswire/ — Oblique Therapeutics AB ("Oblique" or the "Company") today announces the outcome of the rights issue that closed on June 30. The rights issue was fully subscribed and will provide the Company…

Read the full release →

News provided by PR Newswire.